Stay Up-to-Date With COVID-19 Vaccine Development
Technology Networks is committed to keeping you updated with the latest research in this space. Here, you'll find a curation of our latest COVID-19 vaccine-related content.
Why Antibody Testing Should Be Our Next Tool in the Fight Against COVID-19
In this article, Keir Lewis explores how antibody testing can help provide invaluable data that can be used to inform the next stage of the vaccination program rollout.
European Proteomics Infrastructure Consortium – Providing Access
The European Proteomics Infrastructure Consortium providing Access, or EPIC-XS, started in January 2019. It brings together a consortium of world-leading, highly innovative European proteomics facilities with the shared goal of supporting excellent life sciences research in Europe. In this article, Martina O'Flaherty provides an overview of some of the successes of the consortium so far.
COVID-19 Vaccine Safety in Pregnancy
What are the benefits and risks for pregnant persons when it comes to COVID-19 and the vaccines, and does the benefit of the vaccine outweigh the risk of infection? Amber Schmidtke explores the scientific data available.
Measuring Real-Time Cell Therapy Potency With Bioelectronic Assays
As CAR T cells become more popular, the value of potency monitoring will become clearer. Assays that use bioelectrodes to measure the potency of immune cells offer a new approach in cell therapy development.
Examining Risk–Benefit Profiles for Vaccines
In this article, David Elder, explores the risk–benefit profiles for various COVID-19 vaccines and discusses the steps taken by regulatory agencies in response to the occurrence of rare blood clotting events associated with the Oxford–AstraZeneca vaccine.
Teach Me in 10 Hub Page
At Technology Networks we understand the importance of time. That's why we've launched Teach Me in 10 a video series that challenges scientists to present and summarize their research area, a scientific concept, or technology in ten minutes or less.
Stay Up-to-Date With COVID-19 Drug Development
Researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.
Why mRNA Vaccines Could Be a Game Changer
In this article, Amber Schmidtke explores why mRNA vaccines might chart our path to a safer, healthier future.
Gut Microbiome Changes Identified After Spinal Cord Injury
A pilot study led by Professor Phillip Popovich has placed focus on how traumatic SCI might impact the gut microbiome – the population of microbes inhabiting the digestive tract. We spoke to study author Ahmed Zayed to find out more.